David L. Steed
Director Técnico/Científico/I+D en Noveome Biotherapeutics, Inc. .
Perfil
David L.
Steed is currently the Chief Medical Officer & VP-Medical Affairs at Noveome Biotherapeutics, Inc. He previously worked as a Surgery Professor at the University of Pittsburgh and served as the President of The Wound Healing Society.
Cargos activos de David L. Steed
Empresas | Cargo | Inicio |
---|---|---|
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de David L. Steed.
Empresas | Cargo | Fin |
---|---|---|
The Wound Healing Society | Presidente | - |
University of Pittsburgh | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
The Wound Healing Society |
- Bolsa de valores
- Insiders
- David L. Steed